Invention Grant
- Patent Title: Non-invasive determination of likely response to anti-diabetic therapies for cardiovascular disease
-
Application No.: US17838147Application Date: 2022-06-10
-
Publication No.: US11887713B2Publication Date: 2024-01-30
- Inventor: Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
- Applicant: Elucid Bioimaging Inc.
- Applicant Address: US MA Boston
- Assignee: Elucid Bioimaging Inc.
- Current Assignee: Elucid Bioimaging Inc.
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- Main IPC: G16H20/10
- IPC: G16H20/10 ; G16B5/00
Abstract:
Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
Public/Granted literature
- US20230005583A1 NON-INVASIVE DETERMINATION OF LIKELY RESPONSE TO ANTI-DIABETIC THERAPIES FOR CARDIOVASCULAR DISEASE Public/Granted day:2023-01-05
Information query
